Respiratory

COPD exacerbations are heterogeneous clinical events whose severity and prognostic impact are influenced by both the acute episode…

This real-world observational study assessed 218 consecutive patients referred to a dedicated nurse-led ambulatory oxygen therapy (AOT)…

Biologic therapies targeting eosinophilic inflammation hold promise for COPD management. Realising their benefits will require…

Survivors of severe COVID-19 may exhibit immune dysregulation, characterised by reduced naïve and increased senescent and exhausted T cell…

Interstitial lung diseases (ILD) are a heterogeneous group of chronic disorders leading to progressive lung damage and disability. While…

Fibrotic interstitial lung disease (fibrotic ILD) entails a spectrum of different clinical entities characterised by an irreversible…

Each year, the European Lung Foundation (ELF) recognises outstanding research that advances patient-centred care and promotes lung health…

In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the presence…